Vancouver, BC – June 2, 2017: Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (the “Company” or “Liberty Leaf) is pleased to announce the appointment of Mr. Jamie Robinson as Chief Financial Officer of the Company, effective immediately.Mr. Robinson is a Chartered Accountant specializing in accounting, auditing and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Mr. Robinson worked at Deloitte as a Manager focusing on publicly listed and private company audits as well as business reviews, performance enhancement engagements and formal restructuring proceedings. After his public practice experience, he worked as a Senior Financial Analyst at Corinex Communications, performing in-depth financial analysis of currencies, commodities, and financial statements for the purpose of investment and hedge fund trading. Mr. Robinson holds a CA designation and a Bachelor of Commerce from McGill University.
The Company has accepted the resignation of P. Joseph Meagher as Chief Financial Officer and a Director of the Company. The Company wishes to thank Mr. Meagher for his contributions to the Company and commitment in assisting the Company with its transition into the cannabis sector and wishes him all the best in his future endeavours.
Further, the Company has issued an aggregate of 350,000 incentive stock options (the “Options”) to Mr. Robinson and a consultant of the Company. The Options are exercisable at $0.11 per share for a period of two years from the date of grant. The Options have been granted under and are governed by the terms of the Company’s incentive stock option plan.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value added CBD/THC products, biotech research, and supply chain products within this dynamic and fast growing sector.
Liberty Leaf also owns 100% of North Road Ventures –– a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
For further info on the Company please visit www.libleaf.com or email firstname.lastname@example.org.
On Behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements.